The downregulation of p-4E-BP1 and pS6K1 indicated that both STS and RNF152 overexpression inhibited the mTORC1 pathway and STS combined with RNF152 overexpression had the most obvious inhibitory effect on mTORC1 activation (Figure 5A). The gene discussed is RNF152; the disease is telomere syndrome.